You must enable your browser's JavaScript functions, in order to fully utilize the Certaindri.com website.

For more information on how we use JavaScript and Cookies to improve your user experience, please read here.

$60 for 60 Years Donors ** Naomi Prever ** Gladys B. Lipkin ** Rita Miller ** JoAnne Goldberg **  Ann Stern **  $60 for 60 Years Donors ** Rita Seiff  ** Diane Stewart ** Gloria Supran ** Hannah and Stan Scheff  ** Sherrie Bieber **  $60 for 60 Years Donors ** Trudy and Joel Balizer ** Joan Klein ** Rayna Becker ** Roselyn Kessler ** Helene Riffle ** $60 for 60 Years Donors ** The Board of Valencia Palms ** All The Members of Valencia Palms ** Melody Iden **  Hally Shaw ** Joyce Wallach ** Rita Feuerstadt **  $60 for 60 Years Donors ** Boca West Chapter ** Arlene Dworkis ** Woodfield Chapter  ** Alfred Chiuchiolo ** Doreen Berman ** Jeffrey Schachter ** Ronald and Barbara Schubert ** $60 for 60 Years Donors ** Fredda Gleichenhaus ** Helene Brill ** Helen and Sid Rose ** Phyllis and Marshall Goldberg **Helene and Walter Kaley ** Ponte Vecchio West Chapter **  $60 for 60 Years Donors ** Gloria and Ron Berkowitz ** Merle Mash ** Three Island Chapter ** Villa Borghese Chapter ** Shirley Ottchick ** Shelly Studley ** $60 for 60 Years Donors ** Sheila Olin ** Valencia Falls Chapter **  The Board of Valencia Lakes Cancer Research Chapter ** Jan and Jeff Greenhawt **  Althea and Sam Goldberg ** Marlene Waller ** Andrea Press **

FDA Grants IND* to Investigator at University Of Miami School of Medicine for Phase 2 Trial with AEZS-108 in

Published Friday, November 11, 2011 7:00 am

FDA Grants IND* to Investigator at University Of Miami School of Medicine for Phase 2 Trial with AEZS-108 in

Triple-Negative Breast Cancer

Aeterna Zentaris Inc. (a late-stage oncology drug development company) recently announced that the U.S.Food and Drug Administration (FDA) has granted Alberto J. Montero, M.D., Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, an *Investigational New Drug (IND) approval for the initiation of a randomized Phase 2 trial for treatment of luteinizing hormone releasing-hormone receptor (LHRH) positive metastatic breast cancer with the Company's targeted cytotoxic LHRH analog, AEZS-108.

 

Contact:

1192 East Newport Center Drive3848 FAU Blvd.
Suite 230 Deerfield Beach, FL 33442Boca Raton, FL 33431

Toll Free: 877-495-8100Phone: 561-798-3116

The Papanicolaou Corps for Cancer Research, DBA The Pap CorpsTM, Champions For Cancer Research, is a registered 501(c)(3) organization. A copy of the official registration and financial information may be obtained from the Florida State Consumer Services by calling (800) 435-7352, toll free within the state. Registration does not imply endorsement, approval or recommendation by the state.

© Copyright 2011. The Papanicolaou Corps for Cancer Research. ®. All Rights Reserved Terms of Use - Privacy Policy | Site Map | Non Profit Websites by Admin eSolutions